Discover why
‍Mizuho is a name
worth knowing

You already know our work

TECHNOLOGY, MEDIA & TELECOM

Smart Phone Chip Maker Gets Great Reception

A trusted partner for the world’s leading semiconductor IP company

Acting as Active Bookrunner and Joint Global Coordinator, Mizuho ran point on the $5.2 billion IPO of Arm, the world’s largest chip maker for smart phones. Mizuho leveraged its top-tier capabilities, reputation as a trusted partner, and longstanding relationship with Softbank to help get the deal done.

The IPO market springs back to life

The biggest public debut since Rivian in 2021 (on which Mizuho also served as Joint Bookrunner), the deal fueled enthusiasm and provided a much-needed boost to the tech and IPO markets.

$5.2B

IPO

$54.5B

valuation

MORE OF OUR TECHNOLOGY, MEDIA & TELECOM DEALS

Vista Equity Partners

A $4.6 billion acquisition crystallizes IBM’s position in the hybrid cloud

Mizuho acted as Sell-side Advisor to Vista Equity Partners in its sale of Apptio – a leader in financial and operational IT management and optimization software – to IBM. Over the course of the partnership, Vista helped Apptio expand from a single product to a comprehensive IT financial planning platform.

Creating a virtual command center

In a world of growing IT choice and complexity, the Apptio-IBM integration helps companies manage, optimize, and automate tech spend decisions, playing a critical role in shaping how companies evaluate their IT investments.

$4.6B

acquisition

$5T

expected worldwide IT spend in 2024

Learn more about TMT

HEALTHCARE

Financing the future of biopharma

A trusted partner for biopharma’s biggest players

When Bristol Myers Squibb looked to strengthen its capital reserves and pursue attractive acquisition options, it chose Mizuho as active bookrunner for a $13.0 billion notes offering. The nine-part debt issuance helped finance two major deals and further establish Mizuho as a name worth knowing for strong investor relationships and flawless execution. It was also the latest milestone in Mizuho’s decade-long partnership in realizing Bristol Myers Squibb’s ongoing strategic, financing, and risk management objectives.

A promising pipeline of innovative treatments

The transaction helps finance the acquisitions of Karuna Therapeutics and RayzeBio, which strengthen Bristol Myers Squibb’s oncology and neuroscience portfolios by adding novel, best-in-class therapeutics for patients suffering with schizophrenia and certain cancers.

$13B

debt issuance

MORE OF OUR HEALTHCARE DEALS

UNITY Biotech

At the frontier of technology and medicine

As Lead Manager on UNITY Biotechnology’s $85 million IPO, and Joint Bookrunner on its subsequent $45 million common stock offering, Mizuho is helping the groundbreaking biotech company fund clinical trials for promising therapeutic drugs and advance R&D  efforts targeting the mechanisms of aging.

Searching for the fountain of youth

The San Francisco-based biopharma company concentrates on cellular senescence, the process by which a cell ages and stops dividing. By targeting the root causes of age-related diseases, UNITY not only aims to improve our health as we age, but to also lessen the burden on a costly healthcare system.

$85M

IPO

$400M

equity offering

Brightspring

Mizuho helps an innovative healthcare company tap the IPO market

Mizuho Served as Joint Bookrunner on BrightSpring Health Services’ $693 million IPO and concurrent $400 million tangible equity units offering. The capital raise helped deleverage and support the growth of one of the largest independent providers of home and community-based health services.

Compassionate care

Serving more than 400,000 patients daily, BrightSpring cares for chronic, higher-cost, and higher-need patients through a differentiated care model, including long-term specialty care, clinical and pharmacy solutions.

$693M

IPO

$400M

of its common stock

Learn more about healthcare

INDUSTRIALS

Using the Cloud to Get Projects Off the Ground

Driving efficiency and collaboration in construction

Mizuho acted as lead-left bookrunner on a $400 million bond offering for EquipmentShare, a landmark transaction for the company as well as Mizuho. EquipmentShare is a construction technology and equipment solutions provider dedicated to transforming the industry through innovative platforms and data-driven insights.

Optimal execution

Mizuho helped achieve an oversubscribed orderbook, expand EquipmentShare’s investor base, and lower the company’s cost of capital through a successful marketing effort. Mizuho’s relationship with the Company spans lending, capital markets, and strategic advisory roles.

$400M

bond offering

MORE OF OUR INDUSTRIALS DEALS

Rivian

Behind the wheel of one of the biggest IPOs

When electric vehicle company Rivian announced its intention to become publicly traded, it generated a lot of interest from financial firms looking to provide services. Rivian tapped Mizuho for Joint Bookrunner on the public debut that went on to raise $13.7 billion and become the biggest U.S. listing since 2014.

Leveraging a diverse network

Mizuho’s relationship with Rivian began in 2020, building a meaningful partnership through consistent dialogue paired with our capital commitment in the company’s senior secured asset-based revolving credit facility. In March 2023, Mizuho acted as bookrunner on the company’s green convertible senior notes offering.

$13.7B

IPO

One of the biggest public offerings

in history

Brookfield

Mizuho Advises Brookfield on its Triton Take-Private Transaction

Mizuho served as Financial Advisor to Brookfield Infrastructure and provided bespoke backstop financing as Administrative Agent on a $13.3 billion deal that enables Brookfield to position Triton International for success as a private company.

Commerce in Motion

As the world’s largest owner and lessor of intermodal containers, Triton helps drive the global supply chains that propel the international economy. It facilitates the safe and efficient transport of essential goods and supplies that support economic growth and connect cultures.

$13.3B

take-private transaction

~$1T

Brookfield AUM

Learn more about industrials

Learn more about us

Discover who we are

Explore our insights

Find your career

Ready when you are

If you’re looking for a corporate & investment bank as a partner to help make your next big move, and you need the trust that comes with 150 years in business, you’ve come to the right place.

Let's do this
back-to-top-blue